NCT07535398

Brief Summary

The goal of this clinical trial is to learn if synchronous telerehabilitation is effective in patients with elevated pulmonary artery pressure identified by echocardiography (systolic pulmonary artery pressure ≥50 mmHg). It will also evaluate the effects of telerehabilitation on exercise capacity, dyspnea, fatigue, functional status, and quality of life. The main questions it aims to answer are: Does synchronous telerehabilitation improve exercise and functional capacity in these patients? Does synchronous telerehabilitation improve dyspnea, fatigue, psychological status, and quality of life? Researchers will compare synchronous telerehabilitation with breathing and posture exercises to see if telerehabilitation provides greater clinical and functional benefit. Participants will: Be randomly assigned to one of 2 groups Follow an 8-week program, 3 times per week, for 30 minutes per session Perform aerobic, endurance, and strengthening exercises by synchronous telerehabilitation, or breathing and posture exercises in the control group Complete assessments before and after treatment

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
3mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Apr 2026Aug 2026

Study Start

First participant enrolled

April 1, 2026

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

April 10, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 10, 2026

Last Update Submit

April 27, 2026

Conditions

Keywords

Elevated pulmonary artery pressurepulmonary hypertensionsynchronous telerehabilitationexercise capacitypulmonary functionquality of life

Outcome Measures

Primary Outcomes (2)

  • Exercise Capacity

    Change in 6-minute walk distance assessed by the 6-minute walk test to evaluate functional capacity.

    Baseline and at 8 weeks

  • Dyspnea severity measured by the Modified Borg Dyspnea Scale

    Change in dyspnea severity assessed using the Modified Borg Dyspnea Scale. The Modified Borg Dyspnea Scale is a subjective rating scale used to assess the severity of dyspnea at rest and/or during activity. Scores range from 0 to 10, with higher scores indicating greater dyspnea severity and a worse outcome.

    Baseline and at 8 weeks

Secondary Outcomes (6)

  • Fatigue severity measured by the Fatigue Severity Scale

    Baseline and at 8 weeks

  • Physical activity level

    Baseline and at 8 weeks

  • Anxiety and depression measured by the Hospital Anxiety and Depression Scale

    Baseline and at 8 weeks

  • Pulmonary function parameters

    Baseline and at 8 weeks

  • Quality of life measured by the Short Form-36 (SF-36)

    Baseline and at 8 weeks

  • +1 more secondary outcomes

Study Arms (2)

Synchronous Telerehabilitation Group

EXPERIMENTAL

Participants with elevated pulmonary artery pressure identified by echocardiography (systolic pulmonary artery pressure ≥50 mmHg) who meet the study eligibility criteria will receive an 8-week synchronous telerehabilitation program. The program will be delivered 3 days per week, 30 minutes per session, under real-time physiotherapist supervision. The intervention will include aerobic, endurance, and strengthening exercises. Exercise intensity and progression will be individualized according to clinical status, baseline adaptation, and cardiopulmonary exercise test findings. Hemodynamic parameters, oxygen saturation, dyspnea, and fatigue will be monitored during sessions.

Behavioral: Synchronous Telerehabilitation

Control Group

ACTIVE COMPARATOR

Participants with elevated pulmonary artery pressure identified by echocardiography (systolic pulmonary artery pressure ≥50 mmHg) who meet the study eligibility criteria will perform breathing and posture exercises for 8 weeks. Participants in this group will continue routine care and receive weekly motivational follow-up by a physiotherapist. At the end of the study period, participants in the control group may be offered the exercise program if they wish to continue.

Behavioral: Breathing and Posture Exercises

Interventions

A control intervention consisting of breathing exercises, positions to relieve breathing discomfort, breathing control techniques, energy conservation strategies, and posture exercises, performed for 8 weeks, together with routine care and weekly motivational follow-up.

Control Group

A supervised synchronous telerehabilitation program delivered via videoconferencing, including aerobic, endurance, and strengthening exercises for 8 weeks, 3 times per week, 30 minutes per session. The program will be individualized based on participant tolerance and clinical findings, with monitoring of symptoms and physiologic responses during exercise.

Synchronous Telerehabilitation Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 to 65 years
  • Elevated pulmonary artery pressure identified by echocardiography, defined as systolic pulmonary artery pressure (sPAP) of 50 mmHg or higher
  • Clinically stable and receiving medical treatment under cardiology follow-up World Health Organization functional class I or II
  • New York Heart Association (NYHA) functional class I or II
  • Living with a caregiver, family member, or another person who can provide assistance if needed
  • Access to the internet and adequate visual, cognitive, and functional ability to participate in videoconference-based sessions
  • Willing to participate and able to provide informed consent

You may not qualify if:

  • Requirement for oxygen therapy
  • Musculoskeletal problems limiting participation in exercise
  • Ongoing treatment for psychiatric or psychological disorders
  • Cognitive impairment based on Mini-Mental State Examination findings
  • Severe chronic obstructive pulmonary disease (COPD)
  • Other significant cardiac disease that may interfere with participation or assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tokat Gaziosmanpaşa University

Tokat Province, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Hypertension, Pulmonary

Interventions

Respiration

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Respiratory Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Aysel Yıldız Özer, PhD

    Marmara University

    STUDY DIRECTOR

Central Study Contacts

Mehmet Armağan Physiotherapist, Msc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to either a synchronous telerehabilitation group or a control group. The synchronous telerehabilitation group will receive aerobic, endurance, and strengthening exercises, while the control group will perform breathing and posture exercises. Both groups will participate in the program 3 days per week, 30 minutes per session, for 8 weeks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 10, 2026

First Posted

April 17, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

April 29, 2026

Record last verified: 2026-04

Locations